Streetbeat News

ELV

Elevance Health Inc.

https://www.elevancehealth.com

Industry

Medical - Healthcare Plans

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

Open

405.00

Mkt cap

93B

Volume

2.6M

High

408.58

P/E Ratio

14.58

52-wk high

567.26

Low

398.69

Div yield

0.02

52-wk low

397.98

Elevance Health (NYSE:ELV) has outperformed the market over the past 15 years, producing an average annual return of 15.96%. If an investor had bought $100 of ELV stock 15 years ago, it would be worth $929.02 today. The company currently has a market capitalization of $104.25 billion.

Portfolio Pulse from Benzinga Insights

September 14, 2023 | 4:00 pm

Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on Elevance Health (NYSE:ELV) and maintained a price target of $547.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 3:43 pm

Elevance Health's stock price has stagnated in 2023 despite strong earnings growth, expected future growth, and an attractive forward Price/Earnings ratio. The stock is trading nearly 20% below its 52-week high, creating an attractive buy point. The company has grown earnings per share by 10.3% per year over the last five years and is expected to grow EPS by 12.7% per year over the next five years. It also has a forward P/E of 11.9 and a 1.3% dividend, which has been increasing by an average of 14.7% per year over the last 10 years.

Portfolio Pulse from Cory Mitchell

September 01, 2023 | 6:06 pm

Elevance Health (NYSE:ELV) has outperformed the market over the past 10 years by 7.58% on an annualized basis, producing an average annual return of 18.13%. If an investor had bought $100 of ELV stock 10 years ago, it would be worth $529.27 today.

Portfolio Pulse from Benzinga Insights

August 29, 2023 | 5:30 pm

Elevance Health (NYSE:ELV) has outperformed the market over the past 10 years, producing an average annual return of 18.52%. If an investor had bought $1000 of ELV stock 10 years ago, it would be worth $5,373.34 today.

Portfolio Pulse from Benzinga Insights

August 22, 2023 | 5:00 pm

Fitch Ratings has highlighted major credit risks due to persistently high inflation and interest rates. The agency's report points to vulnerabilities in the commercial real estate sector and challenges to China's recovery. Fitch predicts a shallow recession in the US, limited growth in the eurozone, and risks to China's recovery. The bond market continues to face volatility, with ETFs tracking longer-term Treasury bonds and corporate bonds issued by US companies experiencing challenges.

Portfolio Pulse from Piero Cingari

August 17, 2023 | 4:19 pm

Blue Shield of California is reportedly planning to drop CVS Health's Caremark in favor of Amazon and Mark Cuban's Cost Plus Drug Company. This has led to a decrease in the stock prices of several healthcare companies.

Portfolio Pulse from Benzinga Newsdesk

August 17, 2023 | 1:57 pm

Nearly 4 million Americans have lost their Medicaid coverage in the last three months, with an estimated 15 million expected to lose access by the end of the year. This could impact the success of the Democratic party in the upcoming presidential election. The disenrollment is due to the end of the program's continuous enrollment provisions, which were implemented during the COVID-19 pandemic. The states with the highest numbers of people disenrolled are Texas and Florida. Shares of UnitedHealth Group Inc (UNH), Elevance Health Inc (ELV), and CVS Health (CVS) have been affected, as well as the iShares U.S. Healthcare Providers ETF (IHF).

Portfolio Pulse from Natan Ponieman

August 09, 2023 | 11:36 pm

Elevance Health's (NYSE:ELV) short percent of float has risen 4.41% since its last report, with 1.67 million shares sold short, which is 0.71% of all regular shares available for trading. It would take traders 1.0 days to cover their short positions on average. The company has less short interest than most of its peers, with an average of 3.80%.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 6:00 pm

Elevance Health announced that John Gallina will retire as Executive Vice President and CFO later this year. Mark Kaye has been named as his successor and will report directly to Gail K. Boudreaux, President and CEO.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 10:48 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.